Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
5.12
+0.11 (2.20%)
Nov 21, 2024, 3:59 PM EST - Market closed

Elicio Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
32
Market Cap
55.09M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
111, Inc. 2.03B
Owlet 78.61M
Enzo Biochem 31.91M
Aadi Bioscience 25.07M
DBV Technologies 12.52M
Shattuck Labs 6.44M
Lucid Diagnostics 4.19M
Singular Genomics Systems 2.67M
Revenue Rankings